Tesla, Inc. (TSLA)
Verdict history · TSLA
Every call Verdix has made on TSLA.
While a verdict holds, its return keeps accumulating from the day the call was made — it resets only when the verdict itself changes.
Click any date below to read that write-up
When the panel last convened at $342, a WAIT was defensible because mechanical triggers had not fired and the fundamental picture was less dire. What flipped the verdict to SELL at $363 is the weight of new evidence (operating margin at 1.41%, the largest earnings miss in two years, FY2027 estimates cut 11%, and a weekly MACD histogram still widening), which five voices now read as structural overvaluation with no margin of safety, overriding the standing trigger system.
See methodology for how verdicts are produced. Full track record →
The panel’s case against TSLA — and where they disagree.
The case against outweighs the case for at today's price.
NASDAQ · Automotive / AI & Robotics · 2026-06-09 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
SellMEDIUM confidence
Why
Six investing legends on Tesla, and the widest split on Wall Street: five see a declining automaker priced at ~360x earnings for robotaxi dreams, while one sees a $4,600 AI-robotics platform. Why the weight of the analysis lands bearish, and the key levels.Level to watch
Key support 375−5.5% from 396.64
The panel's take
Verdict: SELL · Conviction: MEDIUM · Last price: USD 396.64 (as of 2026-06-09)
This is the most lopsided panel of any name we've run — and, unusually, the disagreement is about what Tesla is. Five of six frameworks conclude that the case against the stock outweighs the case for at $397: an auto business in volume decline, ~2-5% returns on equity, free cash flow guided negative for the rest of 2026, and roughly 80% of a ~$1.3T market cap resting on robotaxi and Optimus businesses that generate almost no revenue today. One framework — The Disruptive-Innovation Seeker's — disagrees emphatically, valuing those same future businesses at multiples of the current price. The weight of fundamentals-grounded valuation sits far below the market price, which is what tips the synthesis bearish.
Key levels
Key levels · TSLA
USD · as of 2026-06-09Analyst consensus target 410 USD · range 25–800
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance runs from ~$422 (the 50%-retrace and prior-supply zone) up through $460 and the ~$485 all-time-high band; key support sits at $375, then the critical $345-360 base (the floor of the recent pullback) and a deeper historical-accumulation zone near $270. The analyst consensus target spans an extraordinary USD 25 to 800 — the widest dispersion on any large-cap — averaging near USD 410.
What legendary investors think
We ran Tesla past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Disruptive-Innovation SeekerGrowth🟢 BullishHigh
Tesla isn't an automaker — it's an AI/robotics platform; robotaxi ($10T TAM) and Optimus are mispriced against an auto yardstick. The base case is ~$4,600, with Optimus the most under-modeled option.
The Macro OpportunistMacro🔴 BearishMedium
"The best horse" — but not at this price: by ~190x forward this macro lens had already stepped aside and sees no reason to return; the auto business is shrinking while the market pays for robotaxi, and the liquidity backdrop won't support a 300x P/E.
The GARP OperatorGrowth (GARP)🔴 BearishMed-High
The business and the valuation "live on different planets" — a "stalwart" earning ~$1.18 in TTM EPS priced at ~360x, with a PEG of ~7-14 on any realistic growth rate; China retail down ~16%.
The Intrinsic-Value ModelerValuation🔴 BearishMed-High
Valuing auto, robotaxi, and Optimus separately yields a base fair value of ~$55-60 (extreme-bull ~$340) — meaning $397 prices in near-simultaneous success across three industries with zero margin of safety.
The Moat CompounderValue🔴 BearishHigh
Outside his circle: a cyclical, capital-intensive carmaker at ~357x earnings and ~4.6% ROE, with a moat narrowing globally (BYD ahead) and exceptional, unpriced key-man risk.
The Forensic SkepticContrarian🔴 BearishMed-High
"The filings tell a different story than the narrative" — Q1 margin flattered by a ~$230M warranty true-down and fading regulatory credits, FCF turning negative, robotaxi a ~20-car pilot; intrinsic value ~$90-130.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- The balance sheet is a genuine strength: ~$44.7B cash, net cash ~$35B, debt/equity ~0.11 — ample firepower to fund the heavy 2026 capex cycle.
- The core auto business is in transition, not growth: FY2025 deliveries fell ~9%, BYD passed Tesla in global EV volume, and brand value has roughly halved over two years amid the Musk political overhang.
- Robotaxi and Optimus are real and progressing (Cybercab in early production, Austin robotaxi live) but generate little revenue today.
The real debate
- What business is this? The Disruptive-Innovation Seeker values Tesla as an AI/robotics platform against a $10T+ autonomy TAM; the Moat Compounder, GARP Operator, and Forensic Skeptic value the visible business — a declining automaker — and call the rest speculative optionality.
- Is the optionality priced or mispriced? The Disruptive-Innovation Seeker says the market under-prices Optimus; the Intrinsic-Value Modeler's sum-of-parts says ~80% of the market cap is future businesses priced at near-certainty, leaving no margin of safety even in an extreme-bull case.
- The near-term cash reality: management has guided free cash flow negative for the rest of 2026 on $25B+ capex — a cash-consuming bet the bulls see as building the future and the bears see as burning capital with no near-term return.
The question it comes down to: Is Tesla an AI/robotics platform whose robotaxi and Optimus businesses justify a ~$1.3T valuation — or a deteriorating automaker whose ~360x multiple prices a future that must arrive quickly, execute perfectly, and resist competition indefinitely?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 396.64 / ~1.3T |
| P/E (TTM / fwd) | ~360x / ~190-210x |
| ROE | ~2.3% |
| Operating margin | ~4.2% (gross ~21%) |
| Dividend yield | 0% (no dividend) |
| Debt / equity | 0.11 |
| Free cash flow | USD 6.2B (FY2025); guided negative for rest of 2026 |
Figures as of FY2025 / Q1 2026; sourced from Tesla IR/SEC filings, GuruFocus, MacroTrends, StockAnalysis. GAAP figures shown; Q1 2026 non-GAAP EPS ($0.41) exceeds GAAP ($0.13), the gap driven mainly by stock-based compensation.
The bottom line
Tesla is the rare case where the panel disagrees not about the price of a known business but about which business is being priced. On the numbers visible today — declining deliveries, ~2-5% ROE, thin auto margins, and free cash flow turning negative — the fundamentals-grounded fair-value estimates from five of six frameworks cluster between roughly $55 and $130, far beneath the $397 market price; the remainder of the valuation is an option on robotaxi and Optimus that the bulls value in the thousands and the bears value at a fraction of what's embedded. What would tip the balance bullish is concrete proof the optionality is converting — unsupervised FSD deployed at scale, a Cybercab fleet generating real revenue at real margins, Optimus reaching volume production — which would validate the platform thesis the price already assumes. What keeps the weight bearish is that, absent that proof, the price demands near-perfect execution across three separate industries at once, against BYD in autos and Waymo in autonomy, while the core business shrinks and burns cash. With analyst targets spanning $25 to $800, the one thing the panel agrees on is that the range of outcomes is exceptionally wide.
contact@verdixhq.com · Published 2026-06-09 · Prices as of 2026-06-09 · Time horizon: 3–12 months · Founder holds a direct position in TSLA · TSLA verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel’s case against TSLA — and where they disagree.
The case against outweighs the case for at today's price.
NASDAQ · Automotive / AI & Robotics · 2026-06-29 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
SellMEDIUM confidence
Why
Six investing legends, and the same fault line as ever: five see a margin-pressured automaker priced at ~350x earnings for robotaxi and Optimus businesses that barely generate revenue, while one sees a $2,000+ AI-robotics platform. Why the weight of the analysis stays bearish, and the key levels.Level to watch
Key support 392−4.4% from 410.17
The panel's take
Verdict: SELL · Conviction: MEDIUM · Last price: USD 410.17 (as of 2026-06-29)
Tesla remains the panel's deepest disagreement about what the company is, and the weight of grounded valuation again lands below the price. Five of six frameworks conclude the case against the stock outweighs the case for it at $410: an auto business with ~5% operating margins and roughly 19% gross margins ex-credits, deliveries only barely positive year-over-year, US volumes down, brand value roughly halved since 2024, and free cash flow guided negative for 2026 on $25B+ of capex — yet roughly $1T of the ~$1.3T market cap rests on robotaxi and Optimus businesses that generate almost no revenue today, and whose own CEO spent June telling investors to "be patient." One framework — The Disruptive-Innovation Seeker's — disagrees emphatically, valuing those same future businesses at multiples of the current price. With fundamentals-grounded fair values clustering far beneath $410 and management itself walking back the timeline that justified the premium, the synthesis stays bearish.
Key levels
Key levels · TSLA
USD · as of 2026-06-29Analyst consensus target 415 USD · range 25–600
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance runs from ~$430 (the lost breakout level and declining short-term trend) up through the ~$465 distribution shelf to the ~$490 early-2026 range high. Key support sits at ~$392 (the 50-week trend, being tested now), then the ~$345 high-volume base, with a deeper historical accumulation zone near $270. The analyst consensus target spans an extraordinary USD 25 to 600 — one of the widest dispersions on any large-cap — averaging near USD 415, essentially at the current price, which captures how completely the auto-yardstick and the AI-platform camps disagree.
What legendary investors think
We ran Tesla past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Disruptive-Innovation SeekerGrowth🟢 BullishHigh
Tesla isn't an automaker — it's a platform AI and robotics company; robotaxi ($5T+ mobility TAM) is in early-adoption S-curve and Optimus is an unpriced option on a $30T labor market. A 5-year base case of $2,000–3,000, with energy (now ~25% of profits) already compounding.
The Moat CompounderValue🔴 BearishHigh
~346x trailing earnings on a ~2.3% ROE is "faith-based speculation priced for perfection." The core auto business earns ~5% margins on stagnant deliveries against BYD, the moat is narrowing, and robotaxi/Optimus sit outside the circle of competence. No margin of safety at $1.4T.
The GARP OperatorGrowth (GARP)🔴 BearishHigh
A cyclical automaker priced like a miracle: a PEG of ~3.8 — "twice my pain threshold" — while Q1 EPS fell ~43% and revenue grew ~2%. You can't compute a sensible PEG when the "G" is negative; this is paying for hope at an unreasonable price.
The Intrinsic-Value ModelerValuation🔴 BearishMed-High
Sum-of-parts: auto + energy justify ~$280B; the remaining ~$1T rests on robotaxi and Optimus that don't yet generate revenue at scale — "faith priced as certainty." Base-case fair value ~$195, roughly 52% below the price.
The Forensic SkepticContrarian🔴 BearishHigh
Margins ex-regulatory-credits are ~19% while management guides FCF negative on $25B+ capex — "consuming capital, not compounding." Robotaxi is a pilot priced as a mature business, and the Musk-attention/xAI conflict is existential, not theoretical. Intrinsic ~$85–110.
The Macro OpportunistMacro⚫ NeutralLow
The robotaxi thesis is real "but laughably early" — ~20 unsupervised cars in Austin vs Waymo's 250+. At ~120x forward earnings in a tightening-liquidity backdrop, "high-multiple growth is where you get your face ripped off"; the tape is on a sell signal and a clean break below ~$358 is the exit.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- The balance sheet is a genuine strength: ~$44B of cash and investments, low debt (D/E ~0.19) — ample firepower to fund the heavy 2026 capex cycle.
- The core auto business is, at best, holding ground: Q1 deliveries grew ~6% off a weak 2025 and gross margin recovered to ~21%, but ~50K of excess inventory was built, US deliveries fell, and the Musk political overhang has roughly halved Tesla's brand value since 2024.
- Robotaxi and Optimus are progressing but pre-revenue: unsupervised robotaxi is live in a few cities at pilot scale, Optimus production is targeted for later in 2026, and management has explicitly told investors the revenue won't be "material" until 2027+.
The real debate
- What business is this? The Disruptive-Innovation Seeker values Tesla against a multi-trillion-dollar autonomy and robotics TAM; the value, GARP, valuation, and forensic lenses value the visible business — a margin-pressured automaker — and call the rest speculative optionality.
- Is the optionality priced or mispriced? The bull says Optimus and robotaxi are under-modeled; the sum-of-parts says ~$1T of the cap is future businesses priced at near-certainty, leaving no margin of safety.
- The near-term cash reality: management guides free cash flow negative for 2026 on $25B+ capex — a bet the bull sees as building the future and the bears see as consuming capital while the core business stalls and the CEO lowers expectations.
The question it comes down to: Is Tesla an AI-and-robotics platform whose robotaxi and Optimus businesses justify a ~$1.3T valuation — or a margin-pressured automaker whose ~350x multiple prices a future that must arrive quickly, execute perfectly against Waymo and BYD, and survive its CEO's divided attention?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 410.17 / ~1.32T |
| P/E (TTM / fwd) | ~350x / ~176x |
| ROE | ~5% |
| Operating margin | ~5% (auto); gross ~21% (~19% ex-credits) |
| Dividend yield | 0% (no dividend) |
| Debt / equity | 0.19x (net cash ~$44B) |
| Free cash flow | ~USD 7B (TTM); guided negative for FY2026 on $25B+ capex |
Figures as of Q1 2026 / June 2026; sourced from Tesla IR/SEC filings, GuruFocus, MacroTrends, StockAnalysis, Electrek. GAAP figures shown; reported automotive margins are flattered by regulatory credits, and Q1 adjusted EPS ($0.41) sits above the depressed GAAP base — part of why the trailing P/E reads near 350x.
The bottom line
Tesla is the recurring case where the panel disagrees not about the price of a known business but about which business is being priced — and three weeks of fresh data did not move that fault line, if anything it hardened it. On the numbers visible today — ~5% operating margins, ~19% gross margins ex-credits, barely-positive deliveries with excess inventory building, brand value halved, and free cash flow guided negative on a $25B+ capex year — the fundamentals-grounded fair-value estimates from five of six frameworks cluster between roughly $85 and $300, beneath the $410 price; the rest of the valuation is an option on robotaxi and Optimus that the bull values in the thousands and the bears value at a fraction of what's embedded. What would tip the balance bullish is concrete proof the optionality is converting — robotaxi scaling from twenty cars to a real fleet generating real revenue at real margins, Optimus reaching production, energy continuing to compound — which would validate the platform thesis the price already assumes. What keeps the weight bearish is that, absent that proof, the price demands near-perfect execution across several industries at once while the core business stalls, the CEO publicly lowers the timeline, and capital burns. With analyst targets spanning $25 to $600, the one thing the panel agrees on is that the range of outcomes is exceptionally wide — and the weight of grounded valuation still sits well below the quote.
contact@verdixhq.com · Published 2026-06-29 · Prices as of 2026-06-29 · Time horizon: 3–12 months · Founder holds a direct position in TSLA · TSLA verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel’s case against TSLA — and where they disagree.
The case against outweighs the case for at today's price.
NASDAQ · Automotive / AI & Robotics · 2026-07-11 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
SellMEDIUM confidence
Why
Six investing legends on the market's most-debated stock: a genuine Q2 delivery beat and a live robotaxi rollout, set against a ~200x forward multiple where nearly every valuation lens puts fair value 60-85% below the price. One archetype sees a trillion-dollar platform; the rest see a car company priced for a story that hasn't shipped. The debate and the key levels.Level to watch
Key resistance 420+3.0% from 407.76
The panel's take
Verdict: SELL · Conviction: MEDIUM · Last price: USD 407.76 (as of 2026-07-11)
Tesla is the panel's clearest valuation call, and it is lopsided: five of six lenses see a stock priced for a future that has not arrived. The business itself is not broken — Q2 2026 deliveries of 480,126 (+25% year over year) beat the Street's ~406K bar by a wide margin and marked the first growth quarter since 2023, the balance sheet holds ~$44.7B of cash with net-cash positioning, and the robotaxi service is genuinely live and unsupervised in Austin and now Miami. The problem is the price. At ~$408 the stock trades near 200x forward earnings and roughly 135x EV/EBITDA, and when the value, forensic, and intrinsic-value lenses model the underlying auto-and-energy business they land between roughly $90 and $260 a share — meaning something like 60-85% of the market capitalization is optionality on robotaxi and Optimus that has, so far, produced a ~20-car Austin fleet, a delayed FSD v15 rewrite, and no disclosed unit economics. The Moat Compounder calls it outside his circle of competence at "a margin of hope"; the GARP Operator, the Forensic Skeptic, and the Intrinsic-Value Modeler each model 60-85% downside to fundamentals; the Macro Opportunist won't fight a hawkish Fed into the July 22 print. Only the Disruptive-Innovation Seeker is a buyer, and her case is explicitly that traditional multiples "miss the point." The panel's prior two reads were also SELL, and nothing in the numbers has closed the price-to-value gap — if anything the Q2 volume was bought with price cuts. The synthesis is SELL, held at MEDIUM because this is a squeeze-prone narrative stock with a fortress balance sheet and a binary catalyst 11 days out — not a name to be short with conviction, but not one the panel can value anywhere near $408.
Key levels
Key levels · TSLA
USD · as of 2026-07-11Analyst consensus target 420 USD · range 200–600
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance starts at ~$420 (this week's high and first overhead supply), then the ~$450-460 shelf where the weekly Supertrend line sits — a weekly close above it is what would flip the trend indicator green — up to the ~$500-510 range ceiling that has capped every rally for six months. Key support sits at ~$390 (this week's low and the fast moving average), then ~$350-360 (the swing low that started the current bounce; losing it breaks the range), with deeper structural support near ~$280-300. The analyst "consensus" is really a non-consensus: formal targets span roughly USD 200 to 600 around a ~$420 average that sits right on top of the current price — the ~$25-to-$600 spread analysts actually cite is not a valuation range so much as an admission that a car-company read and an AI-platform read cannot both be right.
What legendary investors think
We ran Tesla past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue🔴 BearishHigh
"This sits outside my circle — I understand cars, not how to underwrite a robotaxi to a cash flow." The auto business is a real brand with EV scale and the Supercharger network, but it's a capital-intensive, cyclical manufacturer in a price war with BYD — "a commodity fight, not a moat." ROE of ~2.3% is nowhere near his 15% bar; the balance sheet (D/E 0.19) is the one clean checkbox. At ~200x+ earnings, "you're paying for a story, not a cash-generating machine" — auto-only intrinsic value ~$150-220, and the rest is "a margin of hope."
The GARP OperatorGrowth (GARP)🔴 BearishMedium-High
"It's priced as if robotaxi already shipped, while Musk himself says the revenue is a 2027 story." A story stock in a fast-grower costume: trailing P/E near 370x, forward ~181x, TTM EPS down ~43%, best-case forward PEG around 5 — "more than double my avoid line." The one real fast-grower inside is energy storage (+41% a year). Fortress balance sheet means this is not a survival question, "it's strictly: am I overpaying for the growth — and today the answer is yes."
The Disruptive-Innovation SeekerGrowth🟢 BullishHigh
"We're not valuing a car company at 200x earnings — we're valuing an AI and robotics platform that still reports auto revenue as its base." The Miami robotaxi launch on top of Austin is the S-curve inflection skeptics said wouldn't come; Wright's Law keeps driving battery and compute costs down; Optimus is "the option value traditional analysts price at zero." ARK's 2030 target is $2,600 (bull $5,800, bear $700-900), ~90% of it from robotaxi. Musk's near-term revenue reset is "a healthy expectations reset, not a thesis-breaker."
The Intrinsic-Value ModelerValuation🔴 BearishMedium
Two businesses on one ticker. A core-business DCF (auto + energy, 15-20% fading growth, 14% terminal margin, 9.5% WACC) yields ~$54; risk-adjusting the robotaxi/Optimus optionality (25-30% and 15% probability weights, given a shrinking ~20-car fleet and delayed FSD v15) adds ~$45-75 — a base fair value of roughly $100-135, or 67-75% below the price. "About 85% of the market cap is optionality proven only in the narrative. The stock requires you to believe the best possible version of the story with no room to stumble."
The Forensic SkepticContrarian🔴 BearishMedium
"Strip the AI story and you have an automaker with a first-ever annual revenue decline in 2025 and net income down 46%." The Q2 delivery beat "was funded by price cuts after the federal EV credit expired — discounting to hit a number, not resurgent demand," and the stock fell 7-8% on the news. Regulatory credits ($380M in Q1) are "a melting ice cube legislated to zero"; FY2026 free cash flow is guided sharply negative into a $25B+ capex cycle. Sum-of-parts fair value ~$90-130 — "but I'm not shorting a name Musk can move on a keynote."
The Macro OpportunistMacro⚫ NeutralLow-Med
"A name I'd rather watch than own." The robotaxi theme is real and the tape rewards it, but the stock is fighting its 200-day into a Fed that just revised inflation up and kept a July hike on the table — "the wrong backdrop for a 180x-multiple story." Short interest of ~2% means no squeeze cushion, so rallies need real buying. Trading position only, on a confirmed close above $420 on volume with a dovish Fed tilt; stop $365. "There's almost no margin of safety if the July 22 print disappoints."
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- The core business genuinely re-inflected: Q2 deliveries of 480,126 (+25% YoY) beat by ~18% and ended two years of stagnation.
- The balance sheet is a fortress — ~$44.7B cash, net-cash, D/E ~0.19 — so this is not a solvency or survival debate.
- The valuation is extreme on every conventional metric: ~200x forward earnings, ~135x EV/EBITDA, a PEG near 4-5x; the auto-and-energy business alone models to roughly $90-260 a share.
- The entire gap above that — the majority of the market cap — is optionality on robotaxi and Optimus, which today means a ~20-car Austin fleet, a delayed FSD v15, and no disclosed unit economics.
The real debate
- Car company or AI platform? The value, GARP, intrinsic-value, and forensic lenses insist the numbers describe a decelerating automaker subsidized by fading credits; the disruptive lens insists conventional multiples "miss the point" of a platform disrupting mobility, energy, and labor at once.
- What did the delivery beat prove? Bulls read +25% as demand reinflecting; the skeptic reads it as volume bought with price cuts and one-time warranty/tariff tailwinds — "the market's own 7-8% sell-off on the news tells you which."
- Is the optionality worth ~$270-300 a share? That is larger than the entire rest of the company; the bull weights it near-certain, the bears weight it at a fraction given repeated timeline slips.
The question it comes down to: Is Tesla an AI-and-robotics platform whose live robotaxi rollout and delivery reinflection justify looking past a 200x multiple — or a capital-intensive automaker in a price war, priced for the flawless, simultaneous success of two products that have barely shipped, where the honest read is that the risk is skewed hard to the downside?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 407.76 / ~1.5T |
| P/E (trailing / fwd) | ~371–395x / ~181x |
| EV / EBITDA | ~135x |
| Q2 2026 deliveries | 480,126 (+25% YoY; beat ~406K consensus) |
| Q1 2026 auto gross margin ex-credits | 19.2% (aided ~$230M one-time warranty/tariff; below historical 25%+) |
| Regulatory credits (Q1) | USD 380M, −36% YoY (structurally declining) |
| Free cash flow | +USD 1.44B (Q1, |
| Balance sheet | Cash ~$44.7B, net-cash; D/E ~0.19 |
| Energy storage | FY2025 +27%; Q1 2026 deployments 8.8 GWh (−38% QoQ — lumpy) |
Figures as of Q1 2026 (reported Apr 22) and Q2 2026 deliveries (reported Jul 2) / July 11, 2026; sourced from Tesla IR/SEC filings, Electrek, TIKR, stockanalysis.com, MacroTrends, CNBC. Full Q2 financials are due July 22, 2026 — the next real test of whether the delivery beat converts to margin and cash flow. Robotaxi is live and unsupervised in Austin (metro-wide geofence, ~14-20 vehicles) and Miami (launched Jul 6); the FSD v15 rewrite needed to scale the fleet is pushed to late 2026/early 2027. Optimus production is slated to begin at Fremont in Jul/Aug 2026 (management calls 2026 output "impossible to predict"; independent estimates are in the low thousands). Note: some "ARK is buying" summaries are contradicted by 13F filings showing ARK reduced its stake; a well-known skeptic disclosed a fresh short near $416 on June 30.
The bottom line
Tesla is the panel's most one-sided valuation call — and, for the third read running, the synthesis is SELL. The bull case is not imaginary: Q2 deliveries of 480,126 (+25%) genuinely broke two years of stagnation, the robotaxi service is live and unsupervised in two cities, energy storage compounds at double digits, and ~$44.7B of cash removes any solvency question. But the price asks investors to treat the most optimistic version of the robotaxi-and-Optimus future as the base case today, and when five of six lenses model the underlying business they land between roughly $90 and $260 a share — implying 60-85% downside to reconnect with fundamentals. The Forensic Skeptic's read that the delivery "beat" was bought with post-credit-expiry price cuts, the melting regulatory-credit tailwind, the one-time warranty benefit flattering Q1 margins, and free cash flow guided sharply negative into a $25B+ capex cycle all cut the same way: the reported strength is thinner than the headline, and the ~$270-300 a share of embedded optionality rests on a ~20-car fleet and a delayed software rewrite. Only the Disruptive-Innovation Seeker's platform framing — a real, high-conviction view — supports anything near the price, and even the Intrinsic-Value Modeler's bull scenario only gets to roughly flat. What keeps this a MEDIUM-conviction SELL rather than a high-conviction one is exactly what makes it dangerous to short: a fortress balance sheet, a genuine delivery reinflection, a squeeze-prone 2%-short-interest float, and a binary July 22 print that could reprice the narrative either way — which is why even the skeptics on this panel won't press the short. What would change the call is proof, not projection: disclosed robotaxi unit economics with the Austin/Dallas fleet scaling into the hundreds, and auto gross margin holding above 19% ex-credits for two straight quarters. Until the products that justify the multiple actually ship an income statement, the weight of the panel says the risk is skewed down.
contact@verdixhq.com · Published 2026-07-11 · Prices as of 2026-07-11 · Time horizon: 3–12 months · Founder holds a direct position in TSLA · TSLA verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel’s case against TSLA — and where they disagree.
The case against outweighs the case for at today's price.
NASDAQ · Automotive / AI & Robotics · 2026-07-18 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
SellMEDIUM confidence
Why
Six investing legends on Tesla four days before its Q2 print: a genuine delivery beat and a live robotaxi service, set against a ~360x trailing multiple where nearly every valuation lens puts fair value 55-90% below the price. One archetype sees a trillion-dollar platform; the rest see a car company priced for a story that hasn't shipped. The debate and the key levels.Level to watch
Key support 367−3.6% from 380.84
The panel's take
Verdict: SELL · Conviction: MEDIUM · Last price: USD 380.84 (as of 2026-07-18)
Tesla is again the panel's most lopsided valuation call: five of six lenses see a stock priced well ahead of where the numbers can take it. The business is not broken — Q2 2026 deliveries of 480,126 (+25% year over year) beat consensus by a wide margin, auto gross margin ex-credits improved to 21.1% from 16.2%, and the balance sheet holds ~$35.7B of net cash. The problem is the price. At $380.84 the stock trades near 360x trailing earnings against a 4.6% return on equity — down from a 33.6% peak in 2022 — and when the value, forensic, and intrinsic-value lenses model the core auto-and-energy business, they land between roughly $12 and $175 a share, meaning a large share of the market capitalization is optionality on robotaxi and Optimus that remains, by management's own admission, not "meaningful" until 2027. The GARP Operator finds the PEG indefensible even on generous 2028 estimates; the Scuttlebutt Growth Investor's checklist scores just 6 of 15 on a multi-year pattern of missed autonomy timelines; the Intrinsic-Value Modeler's own bull case ($280) sits below today's price; the Forensic Skeptic prices the business at 17x book value against a 3.9% net margin; and the Macro Opportunist won't fight a broken chart into a binary earnings print four days out. Only the Disruptive-Innovation Seeker is a buyer, betting the robotaxi/energy/Optimus convergence justifies the multiple. Nothing here says the story is worthless — energy storage is genuinely strong, and FSD subscriptions are a real, growing recurring-revenue signal — but the price already assumes a level of execution the company hasn't delivered on a timeline it keeps sliding. The synthesis is SELL, held at MEDIUM because the balance sheet gives years of runway and a binary catalyst four days out could move the picture quickly in either direction.
Key levels
Key levels · TSLA
USD · as of 2026-07-18Analyst consensus target 410 USD · range 25–600
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key support sits at $367, the current weekly trend-following level; key resistance sits at $420-430 first, then the $495-500 double top that has rejected price twice. Analyst price targets are unusually dispersed, reflecting deep disagreement over how to value the AI/robotics optionality against the core auto business.
What legendary investors think
We ran Tesla past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Disruptive-Innovation SeekerGrowth🟢 BullishHigh
700K paid robotaxi miles and a 12x geofence expansion in one year is the S-curve inflection point; five-year target $2,600.
The GARP OperatorGrowth (GARP)🔴 BearishHigh
PEG ~6.5-7x even on generous 2028 estimates; Q1's EPS "beat" leaned on one-time warranty/tariff items while free cash flow went negative.
The Scuttlebutt Growth InvestorQuality/Growth🔴 BearishMedium
Checklist score 6 of 15 — R&D up 41% year over year without matching delivered output, plus a multi-year pattern of missed autonomy timelines that fails the non-negotiable management-integrity test.
The Intrinsic-Value ModelerValuation/DCF🔴 BearishMedium
Even the bull-case DCF ($280) lands below today's price; base case ~$95. The burden of proof sits with the bulls, not the skeptics.
The Forensic SkepticContrarian/Deep Value🔴 BearishHigh
3.9% net margin, ~360x trailing P/E, 17x price-to-book against ~$22/share book value; free cash flow collapsed from $6.2B to $1.4B in one quarter.
The Macro OpportunistMacro/Timing🔴 BearishLow
A hawkish Fed removes the liquidity tailwind; the chart sits right on support four days before a binary earnings event — not a name to fight either direction into that print.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- The core EV/auto business is decelerating on profitability (4.2-4.6% operating margin/ROE), even as delivery volumes beat estimates.
- Energy storage is the one segment nearly everyone credits as genuinely strong — though even that had a soft quarter on revenue.
- Robotaxi and Optimus revenue remain immaterial today; management itself has pushed "meaningful" monetization out to 2027.
The real debate
- Is this a car company or an AI/robotics platform? The Disruptive-Innovation Seeker values Tesla on TAM convergence across mobility, energy, and robotics and sees the current multiple as cheap against a multi-trillion-dollar five-year opportunity; the Intrinsic-Value Modeler, Forensic Skeptic, Scuttlebutt Growth Investor, and GARP Operator all independently value the same optionality and find the price already assumes near-certain execution on a timeline the company keeps pushing back.
- Is management's credibility a business risk? The Scuttlebutt Growth Investor explicitly flags a multi-year pattern of missed autonomy timelines as disqualifying under a strict integrity criterion; the Disruptive-Innovation Seeker treats the same slippage as the normal cost of admission for a frontier bet.
The question it comes down to: Does Tesla's robotaxi/Optimus platform reach material, disclosed, profitable revenue on anything close to management's own stated timeline — or does the stock keep paying today for a "next year" that has slipped every year since full self-driving was first promised?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 380.84 / ~$1.23T |
| P/E (TTM / fwd) | ~360x / ~185x |
| ROE | 4.6% (FY2025, down from a 33.6% peak in 2022) |
| Operating margin | 4.2% (Q1 2026) |
| Dividend yield | 0% |
| Debt / equity | 0.106x |
| Free cash flow | USD 1.4B (Q1 2026, down from $6.2B FY2025); guided negative for the rest of 2026 |
Figures as of 2026-07-18; sourced from Tesla Q1 2026 10-Q (SEC EDGAR), FY2025 10-K, and analyst aggregators (StockAnalysis.com, GuruFocus, Macrotrends). Q2 2026 earnings report due July 22, 2026 — not yet reflected above.
The bottom line
Tesla's delivery beat and energy-storage growth are real, and the balance sheet gives it years of runway to fund the robotics bet without financial distress. But five independent frameworks — GARP, quality, DCF, deep-value, and macro/technical — converge on the same conclusion from different angles: the price already assumes a level of robotaxi/Optimus success that hasn't shown up in the numbers yet, and management's own timeline keeps sliding a year at a time. What would change the picture: robotaxi revenue becoming a material, disclosed line item with real unit economics, or a reset toward the range where the independent valuations actually converge.
contact@verdixhq.com · Published 2026-07-18 · Prices as of 2026-07-18 · Time horizon: 3–12 months · Founder holds a direct position in TSLA · TSLA verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel’s case against TSLA — and where they disagree.
The case against outweighs the case for at today's price.
NASDAQ · Automotive / AI & Robotics · 2026-07-25 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
SellMEDIUM confidence
Why
Tesla's Q2 print delivered exactly the split the panel flagged a week out: record revenue and deliveries alongside a collapsing 1.4% operating margin and a swing to negative free cash flow, and the stock fell nearly 18% in a single week. Five of six archetypes hold their bearish signal — several hardening it now that the binary catalyst resolved against the bulls — even as the drop moved price a long way toward, though still above, their own valuation ranges. Only the growth-platform lens still sees a buy in the same numbers. The debate and the key levels.Level to watch
Key support 306−2.2% from 313.03
The panel's take
Verdict: SELL · Conviction: MEDIUM-HIGH · Last price: USD 313.03 (as of 2026-07-25)
What changed since 2026-07-18:
- Price: USD 380.84 → USD 313.03, a -17.80% single-week move ((313.03 − 380.84) / 380.84), the post-earnings selloff the prior article flagged as a four-days-out binary risk.
- Panel composition unchanged (same six archetypes); conviction hardened on the bearish side. The Forensic Skeptic and The GARP Operator hold High; The Macro Opportunist moves Low → Low-Medium now that the binary print resolved bearish and a hawkish Fed removed the liquidity tailwind. The Disruptive-Innovation Seeker remains the lone Bullish, High-conviction dissent.
- Catalyst realized: Q2 2026 earnings (reported 2026-07-22) — record revenue of USD 28.24B (+26% YoY) and 480,126 deliveries (+25% YoY), but adjusted EPS of USD 0.33 missed the ~USD 0.50 estimate, operating margin collapsed to 1.4% from 4.1% a year ago, and free cash flow swung to -USD 1.09B from +USD 1.44B in Q1.
- New risk: the weekly chart confirms Stage 4 (Decline) with a volume-confirmed break of both prior support shelves in one week (275.5M shares vs. a 148-218M trailing baseline); analyst target dispersion also widened further, now spanning USD 130-600.
- Partial offset: FSD subscribers grew 56% YoY to 1.48M, robotaxi operates live across seven metros, and the repricing moved the stock a long way toward the bearish lenses' own modeled ranges — narrowing, not closing, the gap those lenses flagged last week.
- Verdict: SELL, unchanged · Conviction MEDIUM → MEDIUM-HIGH.
Nothing here overturns the prior thesis — the market simply did the repricing five of six lenses argued for. The GARP Operator, The Scuttlebutt Growth Investor, The Intrinsic-Value Modeler, The Forensic Skeptic, and The Macro Opportunist all read the same Q2 print the same way: a real delivery beat funded by margin give-back and a fresh capex ramp (USD 5.79B this quarter, +142% YoY, with full-year 2026 guidance above USD 25B), landing on a business whose earnings quality deteriorated even as revenue grew. The one dissent, The Disruptive-Innovation Seeker, reads the same margin compression as reinvestment for the robotaxi/Optimus S-curve rather than evidence the platform bet is failing. The stock has now fallen close to — but still sits above — the bearish lenses' own modeled ranges (roughly USD 95-220 across value, forensic, and DCF work), so this reads as confirmation of the prior call with a partially, not fully, closed margin of safety. Conviction moves up a notch because the catalyst that kept last week's call at MEDIUM has now resolved decisively bearish, removing the two-sided uncertainty that capped it.
Key levels
Key levels · TSLA
USD · as of 2026-07-25Analyst consensus target 600 USD · range 130–26
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Price broke down through both of last week's support shelves on volume; those levels now flip to resistance, with $325-330 the first overhead hurdle for any bounce and $362-370 the level a reclaim needs to hold above to challenge the stage-4 read. Below current price, $306-310 has already printed twice — this week's partial bar and the prior closed week — making it the immediate, twice-tested floor; a clean break opens $275-280, with $214-220 the deep structural floor last tested in the April 2026 swing low. Beyond R3, the Dec-2025 double top at $495-500 remains the major cap, untested since. Analyst targets widened further post-print, underscoring the same car-company-vs-platform disagreement flagged a week ago.
What legendary investors think
We ran Tesla past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Disruptive-Innovation SeekerGrowth🟢 BullishHigh
"Short-term volatility is the price of long-term returns." FSD subscribers up 56% YoY to 1.48M and the fleet moved to v15 autonomy exactly as the S-curve thesis called for; margin compression reads as reinvestment for the next leg, not a broken platform.
The GARP OperatorGrowth (GARP)🔴 BearishHigh
"You can't pay a growth-stock multiple for a company whose earnings are shrinking while its revenue grows." Record deliveries paired with a 39% EPS miss and auto margin ex-credits down to 16.3%; the PEG math still doesn't work even after an 18% drop.
The Scuttlebutt Growth InvestorQuality/Growth🔴 BearishMedium
"A shipped, working Optimus unit is the only thing that pays it off — and this quarter that count is still zero." R&D +49%, capex +142%, yet Optimus production stays at zero while margins moved the wrong way; robotaxi's metro expansion is the one real green shoot.
The Intrinsic-Value ModelerValuation/DCF🔴 BearishMedium
"The burden of proof still sits with the bulls." Price has converged toward the modeled bull case (~$280) after an 18% drop, but a 1.4% operating margin argues for trimming the base case (~$95-175), not raising it.
The Forensic SkepticContrarian/Deep Value🔴 BearishHigh
"The market just paid a growth multiple for a business that's spending its way to a margin cliff." Still trading near 14x book value with negative free cash flow; the 17.8% drawdown is the market beginning to close the gap, not the end of it.
The Macro OpportunistMacro/Timing🔴 BearishLow-Medium
"When the Fed stops being your friend and the chart confirms it, you don't need a fundamental thesis to get out of the way." Margin compression plus a Fed signaling it's done cutting flipped this from neutral to outright bearish; the prior support shelf already broke, next test is $325-330.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- Q2 delivered a genuine top-line beat (revenue +26%, deliveries +25%) alongside a severe profitability miss (operating margin 1.4%, free cash flow -$1.09B) — every lens reads this as the same signal, differing only in degree of concern.
- Optimus remains pre-revenue with an explicitly "long and flat" ramp (management's own words); nobody on the panel disputes that the monetization timeline keeps sliding.
- The ~18% single-week repricing moved price meaningfully toward — without reaching — the bearish lenses' own valuation ranges.
The real debate
- Is the margin compression reinvestment or deterioration? The Disruptive-Innovation Seeker reads the capex/R&D spike as funding the next growth leg (Cybercab lines, AI4+ compute); The GARP Operator, The Forensic Skeptic, and The Intrinsic-Value Modeler read the identical numbers as earnings quality eroding at a bigger scale.
- Has this week's selloff already done the repricing work, or is there further to go? The Intrinsic-Value Modeler notes price is converging on its own bull case; The Forensic Skeptic and The GARP Operator argue that even down 18%, the stock remains well above the ranges their models support.
The question it comes down to: Did this week's ~18% repricing finally align Tesla's price with its actual earnings power — or is it only the first leg of a longer correction back toward the $95-220 zone where the bearish lenses' independent models converge?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 313.03 / ~$1.01T |
| P/E (TTM) | ~290x (down from ~360x pre-print) |
| Operating margin | 1.4% (Q2 2026, down from 4.1% a year ago) |
| Auto gross margin (ex-credits) | 16.3% (down from 19.2% in Q1 2026) |
| Free cash flow | -USD 1.09B (Q2 2026, down from +USD 1.44B in Q1 2026) |
| Capex (quarterly) | USD 5.79B (+142% YoY); FY2026 guided above USD 25B |
| Cash position | USD 43.5B (+18% YoY) |
| Dividend yield | 0% |
Figures as of 2026-07-25; Q2 2026 results reported 2026-07-22 (CNBC, Electrek, Motley Fool) and OHLC price data. Market cap is estimated pro-rata from the 2026-07-18 figure at the new share price. ROE and debt/equity were not re-disclosed this week (last reported Q1 2026: 4.6% / 0.106x) and are omitted here rather than carried forward as stale.
The bottom line
Tesla's delivery growth and FSD/robotaxi adoption curve are real, and the ~18% drawdown has already done a meaningful part of the repricing the panel's bearish lenses were calling for a week ago — the gap is narrower than it was, even if it isn't closed. What tips this back toward bullish: a second consecutive quarter of margin stabilization (operating margin recovering toward 4%+ without one-time items) or robotaxi/Optimus becoming a disclosed, unit-economics-positive revenue line. What confirms the bearish case further: another quarter of margin compression funded by rising capex with no monetized AI output, or a break of the newly tested $306-310 support that opens the path toward the $275-280 and $214-220 zones where the independent valuation lenses actually converge.
contact@verdixhq.com · Published 2026-07-25 · Prices as of 2026-07-25 · Time horizon: 3–12 months · Founder holds a direct position in TSLA · TSLA verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call TSLA yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NASDAQ · Consumer Discretionary · 2026-08-01 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitHIGH confidence
Why
Tesla at $311 divides our panel 5-to-1 against buying, but the lone bull is making a five-year innovation bet while all five cautious voices object to the business quality itself—not the price. The core tension is whether $25 billion in annual capex is building the infrastructure for a multi-trillion-dollar autonomy platform or burning a cash cushion on optionality that may never arrive, and the answer probably depends on whether auto margins stabilize before the balance sheet does.Level to watch
Key support 307.55−1.2% from 311.21
The panel's take
Verdict: WAIT · Conviction: HIGH · Last price: USD 311.21 (as of 2026-08-01) · Changed from SELL
What changed since 2026-07-25:
- Price: 313.03 → 311.21 (-0.58%)
- Panel: 1 of 6 → 1 of 6 now Bullish — composition also changed: added The Moat Compounder, The Quality Rationalist; removed The Macro Opportunist, The Scuttlebutt Growth Investor
- Trigger: the panel's synthesized verdict would move to BUY if TSLA closes a weekly candle above $340 (the technical scout's invalidation level for the Stage 4 decline) AND auto gross margins ex-credits stabilize above 18% for two consecutive quarters (the fundamental scout / Intrinsic-Value Modeler threshold) — or, alternatively, on a washout to $185–$200 (the Intrinsic-Value Modeler's base value), which would provide a margin of safety even the bears acknowledge. The verdict would move toward SELL / a confirmed breakdown if price closes below $297 on the monthly (the weekly 100% Fib retracement / swing low), which would confirm Stage 4 on the monthly timeframe and open a path toward the volume point-of-control near $250.
- Verdict: SELL → WAIT
Six weeks ago, the panel was a straightforward SELL with the Macro Opportunist and Scuttlebutt Growth Investor both objecting on timing grounds—the bearish case was already dominant. Now, with the Moat Compounder and Quality Rationalist replacing those two voices, the objection has hardened from "the timing is wrong" to "the business itself is fundamentally flawed." The price barely moved (-0.6%), but the composition shift reveals a deeper problem: the voices most respected for assessing business quality and durable competitive advantage are now weighing in, and they are not objecting to price—they are objecting to the entire moat thesis. That is why the same 1-of-6 bullish count now produces WAIT instead of SELL: the lone bull's innovation thesis hasn't broken, but the bears' case has gotten qualitatively stronger, not just louder.
This is a BUY-vs-WAIT split structurally, not BUY-vs-SELL. The Disruptive-Innovation Seeker is the sole bull and she is not framing today's weakness as a call to buy at any price — she's making a 5-year innovation bet where current weakness is where that bet gets made. Every other voice (including the fundamental scout, who explicitly reads WAIT for new capital) agrees the business is deteriorating but acknowledges the optionality. The cautious camp is not split between "business is broken" and "price is wrong" — five voices say the business itself is deeply flawed (The Moat Compounder, The Quality Rationalist, The Forensic Skeptic, The GARP Operator, The Intrinsic-Value Modeler all cite moat erosion, margin compression, and speculative capex). That's a business-quality objection, not a timing call. The fundamental scout — whose job is the most balanced assessment — reads HOLD for existing holders and WAIT for new money, meaning even the most neutral voice stops short of a buy signal today. This tips the synthesis to WAIT: the only bull is a long-duration innovation investor who would likely agree the stock could go lower before her thesis plays out. No panel voice is currently making a high-conviction case to buy today.
Key levels
Key levels · TSLA
USD · as of 2026-08-01Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
What legendary investors think
We ran Tesla, Inc. past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The Intrinsic-Value ModelerValuation/DCF🔴 BearishMed
Signal: The DCF framework values Tesla at $185 per share, with the bull case only reaching $320 under stretched assumptions of 15% revenue CAGR, 15% terminal margins, and a 9% WACC—meaning the current $311 price already discounts near-perfect execution on every optionality bet. Conviction: Conviction is elevated because multiple independent valuation methods (DCF at $75–$185, normalized P/E at $75, sum-of-parts at $42–$150) all point to significant overvaluation, and the auto business deterioration—margins collapsing from 19.2% to 14.6% in a single quarter—is a concrete, hard-to-dispute fact rather than a forecast.
The Moat CompounderValue/Quality/Moat🔴 BearishHigh
Signal: Tesla's auto gross margin ex-credits dropped from 19.2% to 14.6% in one quarter while the company pours $25B into unproven ventures—a business with a 4.6% ROE trading at 345x earnings has no margin of safety by any conceivable standard. Conviction: Conviction is near-certain because the framework's three filters—durable moat, predictable earnings, and rational capital allocation—all fail simultaneously: the moat is eroding in real time, earnings are declining, and management is spending triple historical capex on speculative bets.
The GARP OperatorGrowth (GARP)🔴 BearishHigh
Signal: With TTM revenue declining 2.9% and the PEG ratio effectively unusable because earnings are shrinking, this isn't a business you can explain simply—it's a car company burning $25B in capex while calling itself a robotics platform. Conviction: Conviction is high because the core GARP test—"know what you own"—fails across multiple dimensions: the business definition shifts quarterly, earnings growth is negative making PEG unusable, and even the most optimistic ten-bagger math requires a $13 trillion market cap that the current price already anticipates.
The Forensic SkepticContrarian/Forensic🔴 BearishHigh
Signal: The sum-of-parts analysis assigns roughly $42 per share to the actual operating businesses, meaning the market is pricing over $260 per share—more than $830 billion—of pure optionality on robotaxi and Optimus revenue that has zero commercial track record. Conviction: Conviction is reinforced by the convergence of forensic signals: Q2 free cash flow turned negative (-$1.1B) for the first time in two years, auto margins compressed 460 basis points in a single quarter, and the $25B capex program—triple historical norms—is being classified as growth investment ahead of revenues that may never materialize.
The Disruptive-Innovation SeekerDisruptive Innovation🟢 BullishMed
Signal: The 1.5 million paid FSD subscribers generating billions of real-world driving miles represent an unreplicable data moat, and Wright's Law projects battery costs falling below $50/kWh by 2027, which makes robotaxi unit economics decisively superior to car ownership and unlocks a $5 trillion mobility market. Conviction: Conviction is tempered rather than absolute because while the S-curve thesis is intact, the near-term margin compression (14.6% auto ex-credits) and negative FCF mean the stock could fall meaningfully before the innovation thesis plays out—timing is uncertain even if the five-year destination is clear.
The Quality RationalistMental Models/Quality🔴 BearishHigh
Signal: A 4% net margin, 345x P/E, and $25B in speculative capex on businesses that have produced zero commercial revenue—when a stock falls 13% on an earnings beat because the market finally sees the margin destruction, that is a warning signal worth taking seriously. Conviction: Conviction is high because every mental model applied—inversion, commodity economics, social proof—points in the same direction: the auto business is a low-margin commodity, the narrative premium is built on hope not evidence, and three independent failure scenarios (robotaxi delay, BYD margin pressure, narrative collapse) each have plausible near-term catalysts.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- All six archetypes acknowledge the auto business is deteriorating: margins compressed sharply (19.2% to 14.6% ex-credits in Q2), revenue declined 2.9% YoY TTM, and competition—particularly from BYD—is intensifying.
- Five of six agree the $25B+ capex program represents a massive bet with uncertain payoff; even the lone bull frames it as "the market mispricing an S-curve investment" rather than proven value creation.
- The balance sheet's $35.7B net cash position is universally recognized as the single strongest financial anchor, though all but the Disruptive-Innovation Seeker see it being eroded by the capex burn rate.
- There is consensus that robotaxi and Optimus are the entire valuation premium—remove those optionalities and the stock is worth between $42 and $185 by everyone's math.
The real debate
- The Disruptive-Innovation Seeker sees the $25B capex as infrastructure for a $10T+ TAM and the negative FCF as temporary S-curve investment, while the Moat Compounder, Quality Rationalist, and Forensic Skeptic all see it as empire-building with a low probability of adequate returns—this is not a disagreement about the numbers but about whether the future optionality has any reasonable chance of materializing at scale.
- The Intrinsic-Value Modeler arrives at $185 (40% below current price) through a probability-weighted DCF that grants some option value to robotaxi/Optimus, while the Forensic Skeptic's sum-of-parts gives $42 to the operating businesses—the gap hinges entirely on what probability you assign to the autonomy bet succeeding commercially within a relevant timeframe.
- The GARP Operator and Quality Rationalist both argue the stock is difficult to underwrite because the business definition keeps shifting, while the Disruptive-Innovation Seeker argues backward-looking metrics are precisely the wrong lens for a company building three simultaneous disruptive platforms—this is a philosophical divide between "invest in what you can explain" and "invest in the S-curve before the numbers make sense."
The question it comes down to: Does the $25B+ annual capex program represent the rational infrastructure buildout for a multi-trillion-dollar autonomy and robotics platform, or is it a speculative cash burn propping up a narrative that masks the reality of a deteriorating auto business trading at 345x earnings?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 311.21 / n/a |
| P/E (TTM / fwd) | 345.4x / ~125–161x |
| ROE | 4.6% |
| Operating margin | 4.6% |
| Dividend yield | 0% |
| Debt / equity | 0.08x |
| Free cash flow | USD 6.22B |
Figures as of early August 2026 (TTM basis unless noted); sourced from analyzeportfolio.com, deepresearchglobal.com, and kaplio.com — fundamental scout analysis run 2026-08-01.
The bottom line
Watch the $297 monthly close—that is the weekly 100% Fibonacci retracement and the swing low from the prior consolidation; a monthly close below it would confirm Stage 4 on the monthly timeframe and open a path to the volume point-of-control at roughly $250, a level where even the bears acknowledge the optionality begins to look interesting. On the upside, a weekly close above $340 would invalidate the technical scout's Stage 4 decline framework, and if it coincides with two consecutive quarters of auto gross margins ex-credits stabilizing above 18%, the fundamental scout and Intrinsic-Value Modeler would likely flip constructive. The Q3 2026 earnings report—expected in October—is the next catalyst where the capex narrative collides with margin reality: if free cash flow is negative for a second consecutive quarter and auto margins are still below 15%, the bear case for a move to $250 becomes the base case. For the Disruptive-Innovation Seeker's thesis to gain traction with the rest of the panel, Tesla needs a concrete regulatory milestone on unsupervised FSD—a California or Texas approval—paired with robotaxi revenue that shows up in a 10-Q line item, not a press release.
contact@verdixhq.com · Published 2026-08-01 · Prices as of 2026-08-01 · Time horizon: 3–12 months · Founder holds a direct position in TSLA · TSLA verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call TSLA yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NASDAQ · Consumer Discretionary · 2026-08-08 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitHIGH confidence
Why
Tesla's panel of six investing archetypes delivers a high-conviction WAIT. The business is deteriorating, but the $1.28 trillion price tag is the real blocker, not the company's long-term optionality. Five cautious voices point to the same gap between the current price and reasonable entry levels, and only one long-term bull is willing to endure near-term pain, so the debate comes down to whether robotaxi and Optimus revenues materialize before the auto business forces a painful re-rating.Level to watch
Key resistance 340.49+3.6% from 328.58
Next catalyst
Trigger to confirm the breakdown: A weekly close below $316.43 (the EMA200) would confirm Stage 4 and open the path to the $250–255 high-volume POC zone.The panel's take
Verdict: WAIT · Conviction: HIGH · Last price: 328.58
What changed since 2026-08-01:
- Price: 311.21 → 328.58 (+5.58%)
- Panel: 1 of 6 → 1 of 6 now Bullish — composition also changed: added The Macro Opportunist; removed The Moat Compounder
- Trigger: To BUY: a weekly close above $340.49 (breaking the Stage 4 downtrend and reclaiming the high-volume cluster) OR a washout into the $200–250 zone with bullish RSI divergence (hitting The Intrinsic-Value Modeler's $210, The Quality Rationalist's $250, and the all-time volume POC at $250.69). To SELL: a weekly close below $316.43 (EMA200 breakdown confirming Stage 4) coupled with another robotaxi/Optimus timeline slip past 2027 — the re-rating from tech to auto that The Quality Rationalist and The Forensic Skeptic warn about.
- Verdict: WAIT (unchanged)
Since early August, the business picture has worsened: Q2 earnings missed consensus by 40%, free cash flow flipped deeply negative, and the Cybercab, Semi, and Megapack timelines all slipped. Yet the stock drifted higher on narrative inertia rather than fundamental improvement. The addition of The Macro Opportunist introduces a liquidity-drain lens that reinforces the WAIT: in a Fed tightening cycle, a cash-burning story stock is swimming against the tide, and the gap between a $1.28T valuation and deteriorating fundamentals has only widened.
The panel is not split on business quality. Even the bears (The Intrinsic-Value Modeler, The Macro Opportunist, The Quality Rationalist, The GARP Operator) largely respect Tesla's optionality and balance sheet. The lone genuine SELL voice (The Forensic Skeptic) is outnumbered 7:1 within the cautious camp by voices saying "right company, wrong price," which is the signature of a WAIT, not a HOLD. The Disruptive-Innovation Seeker's lone BUY is a 5-year conviction call that concedes near-term pain; it doesn't offset eight cautious voices all pointing to the same gap between a $1.28T price and a deteriorating near-term P&L. Price is the blocker, and multiple specific entry levels are named, so the WAIT has a destination.
Key levels
Key levels · TSLA
USD · as of 2026-08-08Key support & resistance — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
What legendary investors think
We ran Tesla, Inc. past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The Intrinsic-Value ModelerValuation/DCF🔴 BearishMed
Signal: Strip out the auto business at generous assumptions and the market is paying $1.09 trillion for the robotaxi/Optimus/AI option portfolio, a figure that would require $55-60B in annual operating income from businesses with zero commercial revenue today. Conviction: This is high conviction because five independent signals converge on the same conclusion: declining deliveries, CFO-guided negative FCF, collapsing ROE, zero insider buying, and a weekly Stage 4 downtrend.
The Forensic SkepticContrarian/Forensic🔴 BearishHigh
Signal: At 296x trailing earnings, with revenue declining, the CFO explicitly guiding negative free cash flow through year-end, and every major product timeline slipping, Tesla is a momentum stock priced for a miracle, not a value investment. Conviction: The chasm between narrative and tangible reality reinforces this: tangible book value is roughly $23 per share against a $325 stock, and no insider has purchased shares on the open market.
The Macro OpportunistMacro/Timing🔴 BearishMed
Signal: In a Fed tightening cycle with liquidity draining, a negative-free-cash-flow story stock at 295x earnings with $25B+ in annual capex is the wrong asset at the wrong time, and the weekly Stage 4 downtrend confirms the market is already repricing it. Conviction: What holds this back is Tesla's potential for sharp short squeezes. The direction is clear, but the entry timing demands patience, and a weekly close above $340 would invalidate the bearish thesis.
The Disruptive-Innovation SeekerDisruptive Innovation🟢 BullishMed
Signal: With billions of miles of proprietary driving data, vertical integration from chip to charger, and Wright's Law driving battery costs toward $50/kWh, Tesla offers a 10:1 asymmetric payoff with a probability-weighted 5-year target of $2,075 per share. Conviction: This comes with a concession baked in: near-term pain is real, and negative FCF, timeline slips, and Musk distraction risk mean the 5-year thesis requires surviving a potentially severe 1–2 year drawdown.
The GARP OperatorGrowth (GARP)⚫ Neutraln/a
Signal: With growth decelerating toward 15-20% and the P/E still elevated at 60-70x, the PEG ratio sits above 3.0, triple the 1.0 maximum that separates an investment from a speculation. Conviction: One unresolved dependency holds this back: if autonomy or energy re-accelerates growth, the PEG could become justifiable, but until that materializes, the numbers don't support the price.
The Quality RationalistMental Models/Quality🔴 BearishMed
Signal: ROE has collapsed from 27% to 5.5%, operating margins sit at 5%, and the CFO guides for negative free cash flow, yet the market pays 296x earnings as if the robotaxi narrative justifies ignoring every deteriorating fundamental. Conviction: Two independent signals point the same direction: the technical breakdown confirms the fundamental deterioration, and zero insider buying at $311 shows that those closest to the business see no value either.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- Tesla's balance sheet is a genuine strength: $44B in cash against negligible debt, buying time for the optionality bets to play out.
- The core auto business is deteriorating: deliveries declining (~1.56M forecast vs 1.64M in 2025), margins compressing, and negative revenue growth on a TTM basis.
- The robotaxi, Optimus, and AI optionality is real and substantial (no one on the panel dismisses it), but every product timeline has already slipped out of 2026.
- The technical picture on the weekly timeframe is bearish: Stage 4 downtrend, price below key moving averages, RSI sub-40 with no bullish divergence.
- Insider activity shows no open-market buying, reinforcing caution across the panel.
The real debate
- The Disruptive-Innovation Seeker sees the $25B annual capex as the largest industrial investment in history, the price of building the future. The Quality Rationalist and The Intrinsic-Value Modeler see the same spend as value destruction with no credible timeline for commercialization.
- The Forensic Skeptic believes Tesla will eventually be re-rated as an auto manufacturer worth $100–150/share. The Disruptive-Innovation Seeker believes the market is still mispricing it as an auto company when it's really an AI/robotics platform worth $2,000+/share.
- The GARP Operator demands a PEG ratio of 1.0 or below before considering an entry, while The Disruptive-Innovation Seeker argues that near-term earnings are irrelevant because the payoff is a discontinuous S-curve inflection, not linear growth.
The question it comes down to: Will Tesla's $25B+ annual capex translate into commercial robotaxi or Optimus revenue before deteriorating auto fundamentals and a tightening liquidity regime force the market to re-rate the stock from tech multiples to auto multiples?
The bottom line
- Trigger to confirm the breakdown: A weekly close below $316.43 (the EMA200) would confirm Stage 4 and open the path to the $250–255 high-volume POC zone.
- Level to reclaim: A weekly close above $340.49 on expanding volume would break the Stage 4 downtrend and suggest a bottom is forming.
- The accumulation zone: A washout into $200–250 with bullish RSI divergence would align with The Intrinsic-Value Modeler's $210 base case and The Quality Rationalist's value area at $250.
- Next catalyst: FSD v13 achieving unsupervised Level 4 regulatory approval in a major US market by mid-2027 would fundamentally re-rate the optionality from speculative to probable.
- Risk to monitor: If negative free cash flow persists into Q2 2027 with no demonstrable robotaxi or Optimus shipment progress, the market's patience could run out, triggering the re-rating from tech multiples to auto multiples.
contact@verdixhq.com · Published 2026-08-08 · Prices as of 2026-08-08 · Time horizon: 3–12 months · No direct position held in TSLA · TSLA verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call TSLA yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NASDAQ · Consumer Discretionary · 2026-08-15 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitHIGH confidence
Why
Tesla divides the panel into one bull betting on an AI and autonomy S-curve and five cautious voices who admire the company but cannot justify paying 293 times earnings for a business with declining revenue and vanishing margins. The debate turns on whether robotaxi profits will arrive fast enough to validate today's price before the deteriorating auto fundamentals inflict real damage.Level to watch
Key support 340.49−0.5% from 342.27
Next catalyst
Bullish invalidation level: A weekly close above $375 — the confluence of the weekly EMA20, EMA50, and 61.8% Fibonacci retracement — would flip the technical picture and confirm the bull thesis is regaining control.The panel's take
Verdict: WAIT · Conviction: HIGH · Last price: 342.27
What changed since 2026-08-08:
- Price: 328.58 → 342.27 (+4.17%)
- Panel: 1 of 6 → 1 of 6 now Bullish — composition also changed: added The Asymmetric Bargainer; removed The Macro Opportunist
- Trigger: BUY on a weekly close above $375 (confluence of weekly EMA20, EMA50, and 61.8% Fibonacci; the Technical Scout's invalidation level). Alternatively, BUY on a pullback to $200–$250, where The Asymmetric Bargainer, The Intrinsic-Value Modeler, and The Forensic Skeptic all see an asymmetric payoff with limited downside. SELL if a weekly close below $297–$300 confirms Stage 4 breakdown and invalidates the bull thesis on a structural level.
- Verdict: WAIT (unchanged)
The panel remains split 1-bull to 5-cautious, unchanged from August even as the stock rose 4.2%. The price moved higher on AI optimism, but the underlying auto fundamentals worsened — Q2 showed negative free cash flow and a capex surge — so the cautious voices are now dug in more firmly on the price/timing objection. The Asymmetric Bargainer joins the panel this round and lands squarely with the cautious camp, reinforcing the WAIT verdict: the business story hasn't improved, the price has simply become a bigger ask.
This is a textbook BUY-vs-WAIT split: The Disruptive-Innovation Seeker says buy now on the innovation S-curve thesis, while every other voice — including those who admire the business (The Intrinsic-Value Modeler, The GARP Operator, the Technical Scout) — says the company has real assets and optionality but $342 is the wrong entry price. No cautious voice argues Tesla's business is broken; they all want a lower price. That structural split (one bull vs. seven voices saying "great story, terrible price") routes directly to WAIT under Step B.
Key levels
Key levels · TSLA
USD · as of 2026-08-15Key support & resistance — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
What legendary investors think
We ran Tesla, Inc. past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The Intrinsic-Value ModelerValuation/DCF🔴 BearishMed
Signal: At $342, the market is discounting a bull-case autonomy scenario that requires $340/share of present value from robotaxi revenue that is at least 3–5 years away from being material, while current financials show revenue declining 2.9% and operating margins compressed to 1.4%. Conviction: Conviction strengthens because three independent valuation methods — a DCF base case at ~$200, a normalized P/E comparison, and a sum-of-parts — all converge on a value 40% below the current price, leaving little room for error.
The Forensic SkepticContrarian/Forensic🔴 BearishMed
Signal: The Q2 filing reveals negative free cash flow of $1.1 billion alongside a 142% surge in capex to $25 billion, while revenue shrinks and net margin thins to 3.7% — a business burning cash to chase an unproven autonomy payoff. Conviction: Conviction is tempered by one uncomfortable fact: the $44 billion cash pile against only $6.6 billion of debt means Tesla can fund this experiment for years without a capital crisis, so a short position needs precise timing rather than just a valuation argument.
The Quality RationalistMental Models/Quality🔴 BearishHigh
Signal: Return on equity sits at roughly 5% — a business earning well below its cost of capital while priced at 293 times earnings fails the most basic test of a wonderful company, regardless of how compelling the robotaxi narrative sounds. Conviction: High conviction because the deterioration is visible across multiple dimensions that matter: falling deliveries, vanishing margins, insider selling with no open-market buying, and a technical picture breaking down — no single contested assumption props this up.
The GARP OperatorGrowth (GARP)🔴 BearishHigh
Signal: The PEG ratio is meaningless because growth is negative, but a P/E of 293x on a company with falling sales is the polar opposite of what a GARP framework can tolerate, no matter how pristine the balance sheet. Conviction: Conviction is high because the story is too complicated — EVs plus robotaxis plus robots plus AI plus energy — and my best picks have always had one simple growth driver, not five speculative ones bundled together.
The Disruptive-Innovation SeekerDisruptive Innovation🟢 BullishMed
Signal: Wright's Law is compressing battery costs toward $60/kWh by 2028, and Tesla's vertically integrated 4680 cell production, Dojo compute, and $25 billion capex build-out position it to capture the next S-curve inflection across EVs, robotaxis, and energy storage simultaneously. Conviction: Conviction is held back because the robotaxi thesis depends on a single binary catalyst — regulatory approval of unsupervised FSD in a major market — and until that arrives, the bull case remains a probability-weighted scenario, not a confirmed trajectory.
The Asymmetric BargainerContrarian/Deep Value🔴 BearishMed
Signal: The Dhandho framework fails on the first criterion: downside is not limited — a break below $340 opens a path to $300 and possibly $250, a 27% loss with no floor provided by the underlying auto business at these multiples. Conviction: Conviction is reinforced by the insider activity pattern: $32 million in net selling over 90 days with zero open-market purchases, a clear signal that those closest to the business see no compelling value at current prices.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- All six voices agree Tesla owns real, valuable assets: a strong balance sheet with $44 billion in cash against minimal debt, a legitimate EV manufacturing capability, and genuine optionality in energy storage and autonomy. No one argues the company faces existential risk.
- Every cautious voice — five of six — objects on price and timing, not on the quality of the business itself. The bearishness is about the entry level, not a thesis that Tesla is broken.
- All recognize that the robotaxi and AI narrative is the swing factor: it is the only path that justifies the current price, and its timeline and probability remain deeply contested rather than settled.
The real debate
- The Disruptive-Innovation Seeker sees an S-curve inflection approaching and treats the $25 billion capex as the necessary build-out for a platform company crossing the chasm; The Quality Rationalist sees the same capex as a Red Queen arms race that destroys returns on capital in an industry with no durable moat.
- The Intrinsic-Value Modeler can build a DCF reaching $340 only under a bull case that assumes perfect autonomy execution, while The Disruptive-Innovation Seeker assigns a 60% probability to a $1,200 base case. The gap is not about the numbers — it is about what probability you attach to a future that has no historical precedent.
- The Forensic Skeptic and The Asymmetric Bargainer both want a price where downside is limited by fundamentals, not by narrative. The Disruptive-Innovation Seeker argues that waiting for that price means missing the exponential move that traditional valuation models systematically fail to capture.
The question it comes down to: Is the robotaxi and AI opportunity probable enough and near enough to justify paying $342 today, or does the deteriorating auto business and the lack of any margin of safety mean the burden of proof still sits with the bulls?
The bottom line
- Bullish invalidation level: A weekly close above $375 — the confluence of the weekly EMA20, EMA50, and 61.8% Fibonacci retracement — would flip the technical picture and confirm the bull thesis is regaining control.
- Bearish breakdown trigger: A weekly close below $297–$300 would confirm a Stage 4 breakdown on the weekly chart and open a path toward the volume POC near $250, where several cautious voices would reassess the balance of upside to downside.
- Margin stabilization to watch: Two consecutive quarters of operating margin above 10% would signal the EV price war is ending and that the auto business can fund the autonomy bet rather than drain it.
- Robotaxi catalyst: Concrete regulatory approval for unsupervised FSD in a major state like Texas or California, or a disclosed robotaxi commercial launch with unit economics, would move the autonomy thesis from speculative to tangible.
- Insider sentiment signal: Open-market insider buying at current levels — particularly from Musk or senior leadership with their own cash — would sharply undercut the cautious argument that even insiders see no value here.
contact@verdixhq.com · Published 2026-08-15 · Prices as of 2026-08-15 · Time horizon: 3–12 months · No direct position held in TSLA · TSLA verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel’s case against TSLA — and where they disagree.
The case against outweighs the case for at today's price.
NASDAQ · Consumer Discretionary · 2026-08-22 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
SellHIGH confidence
Why
Six investing frameworks weigh in on Tesla at $363 after operating margins collapsed to 1.41% and the stock missed earnings by the widest margin in two years. Five voices call SELL with high conviction, seeing no margin of safety at 320x trailing earnings; the lone neutral voice withholds only because the autonomy and robotics optionality has not yet been disproven.Level to watch
Key resistance 374.04+3.1% from 362.86
Next catalyst
Weekly close above $380.27: A weekly close above the EMA50 and the Macro Opportunist's bullish invalidation level would signal the downtrend is broken and flip the panel to BUY regardless of fundamentals.The panel's take
Verdict: SELL · Conviction: HIGH · Last price: 362.86 · Changed from WAIT
Panel: 0 Bullish · 1 Neutral · 5 Bearish → SELL
What changed since 2026-08-15:
- Price: 342.27 → 362.86 (+6.02%)
- Panel: 1 of 6 → 0 of 6 now Bullish — composition also changed: added The Macro Opportunist; removed The Quality Rationalist
- Trigger: BUY on a weekly close above $380.27 (the weekly EMA50 and the Technical Scout's bullish invalidation level), which would signal the weekly downtrend is broken and momentum is repairing. Alternatively, BUY on a pullback to $200–$250 where multiple valuation frameworks (The Intrinsic-Value Modeler DCF, The Forensic Skeptic intrinsic value, The Asymmetric Bargainer Dhandho upside scenario) converge on an asymmetric payoff with limited downside.
- Verdict: WAIT → SELL
When the panel last convened at $342, a WAIT was defensible because mechanical triggers had not fired and the fundamental picture was less dire. What flipped the verdict to SELL at $363 is the weight of new evidence (operating margin at 1.41%, the largest earnings miss in two years, FY2027 estimates cut 11%, and a weekly MACD histogram still widening), which five voices now read as structural overvaluation with no margin of safety, overriding the standing trigger system.
Five of six voices are Bearish and the sixth is Neutral — there is no bull case on this panel. The prior WAIT trigger (weekly close above $375 to BUY, pullback to $200–$250 to BUY, weekly close below $297–$300 to SELL) has NOT FIRED: price at $362.86 has not closed above $375, not pulled back to $250, and not broken below $297. However, the panel's own verdict overrides that standing WAIT because the fundamental and valuation deterioration has deepened since the prior article — operating margin now 1.41%, Q2 2026 miss the largest in two years, FY2027 estimates cut 11%, and the weekly MACD histogram still widening downward. Five voices independently conclude the stock is overvalued at $363 with no margin of safety; the lone Neutral (The Disruptive-Innovation Seeker) only withholds because the innovation optionality has not yet been disproven. A WAIT at $342 two days ago was defensible; at $363 with this deterioration, the panel shifts to SELL.
Key levels
Key levels · TSLA
USD · as of 2026-08-22Analyst consensus target 395.34 USD · range 125–600
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance sits at $374–$380, a tight band where the weekly EMA20 ($374.04) and EMA50 ($380.27) converge with the 61.8% Fibonacci retracement of the weekly swing ($374.33) — this zone rejected price on the recent rally and must be reclaimed for any bullish resolution. Key support at $347.17 is the 38.2% Fibonacci retracement of the monthly swing from $101.81 to $498.83; this held on the last weekly close but is being tested. Below that, $340.49 marks the weekly 78.6% Fibonacci, and $316.84 is the weekly EMA200 — the line in the sand separating a Stage 3 correction from a full Stage 4 bear market. The analyst consensus target of $395.34 sits above current price but the $475 spread between the $125 low and $600 high reflects extreme disagreement that dilutes the signal.
What legendary investors think
We ran Tesla, Inc. past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The Intrinsic-Value ModelerValuation/DCF🔴 BearishMed
Signal: At $362.86, the market is pricing a terminal margin structure no automaker has ever achieved: even the bull-case DCF, which assumes 25% operating margins and a decade of 20%+ revenue growth, reaches only $280 per share, still 23% below the current price. Conviction: Confidence in the bearish call is reinforced by the fact that all three DCF scenarios (bear at $18, base at $45, bull at $280) sit below the current price, meaning no plausible set of assumptions can bridge the gap without invoking narrative probabilities that the numbers do not support.
The GARP OperatorGrowth (GARP)🔴 BearishHigh
Signal: The PEG ratio clocks in at 5.06, more than triple the GARP ceiling of 1.5, and earnings per share are shrinking 4.9% year-over-year while revenue grows 25%, a textbook case of negative operating leverage inside a fast-grower that has stopped growing earnings. Conviction: The conviction level hits 80% because earnings are not just slowing, they are declining, and the PEG ratio is so far beyond any tolerable threshold that even a dramatic margin recovery would take quarters to bring the multiple into an acceptable range for a fast-grower framework.
The Forensic SkepticContrarian/Forensic🔴 BearishMed
Signal: Operating margin has collapsed to 1.41% and the trailing P/E sits at 319x, a combination that reveals the market is pricing a technology-growth narrative onto a business that is currently earning like a capital-intensive auto manufacturer. Conviction: What solidifies the bearish stance is the direction of travel: operating margin fell to 1.41%, Q2 missed by 36.5%, FY2027 estimates were cut 11% in 90 days, and insiders sold a net $32M with zero open-market purchases, four independent signals all pointing the same way.
The Macro OpportunistMacro/Timing🔴 BearishMed
Signal: The weekly MACD histogram is widening downward at -5.54 with price below all key weekly EMAs, a distribution pattern that collides with the 10-year yield rising to 4.7% to create a toxic environment for a 320x P/E asset. Conviction: Conviction is restrained to 60% because the $27.4B net cash position and $18.7B in operating cash flow create a structural floor that prevents a full-blown collapse, which is the only factor standing between the deteriorating technicals and a far more aggressive bearish stance.
The Disruptive-Innovation SeekerDisruptive Innovation⚫ NeutralLow
Signal: Tesla sits at the convergence of multiple S-curves (autonomy, energy storage, robotics), and the $43.5B cash fortress funds continued R&D without dilution risk, but near-term financials are deteriorating with operating margin at 1.41% and the Q2 2026 miss the largest in two years. Conviction: The neutral rating persists because the innovation optionality has not been disproven: a single FSD regulatory approval or a margin-stabilizing earnings beat could shift the narrative, and until that catalyst resolves, the framework cannot go fully bearish despite the ugly near-term numbers.
The Asymmetric BargainerContrarian/Deep Value🔴 BearishMed
Signal: The Dhandho framework passes only one of four tests: the business is too complex, downside is large (a re-rating to 30x earnings implies a 70%+ decline), and the 15%-probability upside scenario does not offset the 55%-probability downside, leaving no 'heads I win, tails I don't lose much' setup on the table. Conviction: The bearish call draws strength from a negative expected value: the weighted average of the three scenarios (55% chance of a 50-70% decline, 30% chance of flat returns, 15% chance of doubling) produces a roughly 20-30% expected loss, which fails every Dhandho requirement for an asymmetrical bet.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- All agree the balance sheet is a fortress: $43.5B cash, $27.4B net cash, debt-to-equity of 0.18, and ample operating cash flow at $18.7B.
- All agree operating margins have deteriorated to a dangerously thin 1.41%, compressing toward legacy auto levels and erasing the historical tech premium.
- All agree the valuation is extreme at roughly 320x trailing earnings, a multiple that embeds expectations no automaker has ever delivered.
- All agree the Q2 2026 earnings miss was significant (the largest in two years at -36.5%) and that the earnings trajectory is pointing down.
- Five of six agree the stock is overvalued at $363 with no margin of safety; the lone Neutral voice dissents on timing, not on whether the price is supported by current fundamentals.
The real debate
- The Disruptive-Innovation Seeker sees the innovation optionality as still alive and worth waiting for, while The Asymmetric Bargainer sees the complexity as a direct reason to walk away: the same platform thesis that creates upside also makes the business too complex to underwrite with confidence.
- The Intrinsic-Value Modeler argues that even the most optimistic DCF ($280) cannot reach the current price, while The Disruptive-Innovation Seeker counters that DCF frameworks cannot capture the non-linear payoff of a successful autonomy platform. The debate is about whether optionality is fairly valued or overvalued.
- The Macro Opportunist focuses on the weekly MACD histogram widening as a distribution signal that could extend, while The Forensic Skeptic focuses on the fundamental deterioration. These are technical and fundamental bear cases arriving at the same destination through different paths.
The question it comes down to: Has the deterioration in core automotive profitability (1.41% operating margin) permanently broken the growth narrative, or can the innovation optionality (FSD, robotaxi, energy storage) still justify paying 320x trailing earnings while waiting for the next catalyst?
The bottom line
- Weekly close above $380.27: A weekly close above the EMA50 and the Macro Opportunist's bullish invalidation level would signal the downtrend is broken and flip the panel to BUY regardless of fundamentals.
- Q3 2026 margin print: If operating margin stabilizes above 5% in the next quarterly report (likely late October 2026), the core bear thesis of accelerating deterioration would be challenged.
- Pullback to $200–$250: A decline into the range where the Intrinsic-Value Modeler's DCF, the Forensic Skeptic's normalized P/E, and the Asymmetric Bargainer's Dhandho upside scenario all converge would create an asymmetric payoff even without an innovation catalyst.
- FSD regulatory catalyst: A formal regulatory approval for unsupervised FSD in a major market (California, Texas, or China) would shift the narrative from cost-cutting to software revenue and could compress the multiple even before earnings recover.
- Weekly close below $316.84: A close below the weekly EMA200 would confirm a Stage 4 decline per the Macro Opportunist's framework and could accelerate selling as institutional distribution becomes a full breakdown.
contact@verdixhq.com · Published 2026-08-22 · Prices as of 2026-08-22 · Time horizon: 3–12 months · No direct position held in TSLA · TSLA verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel also debated